VitaSpring Biomedical (VSBC) Stock Statistics & Valuation Metrics

VitaSpring Biomedical has a market cap or net worth of $10.35M. The enterprise value is $2.29M.

VitaSpring Biomedical has 207,030,030 shares outstanding. The number of shares has decreased by -2.65% in one year.

VitaSpring Biomedical’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.70%.

The current PE Ratio of VitaSpring Biomedical is ―. VitaSpring Biomedical’s PEG ratio is 0.00.

In the last 12 months, VitaSpring Biomedical had revenue of 0.00 and earned -415.37K in profits. Earnings per share was >-0.01.

In the last 12 months, operating cash flow was 4.18K and capital expenditures 0.00, giving a free cash flow of 4.18K billion.

VitaSpring Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

VitaSpring Biomedical upcoming earnings date is ―, ―.

VitaSpring Biomedical as a current ratio of <0.01, with Debt / Equity ratio of 0.00%

In the past 12 months, VitaSpring Biomedical has paid 29.96K in taxes.

VitaSpring Biomedical EV to EBITDA ratio is -551.41, with an EV/FCF ratio of -77.02K.

VitaSpring Biomedical has $8.17K in cash and marketable securities with $0.00 in debt, giving a net cash position of $8.17K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for VitaSpring Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―